Physician profile
Vikram Garg
NPI 1760491054
$730.47
in general payments reported to CMS, 2019-2025
13 companies · $310 in 2025
The $310 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2022: $13.50 · 2023: $75.37 · 2024: $211 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $123.12 | 2024 | Zepbound |
| Genzyme Corporation | $100.00 | 2019 | |
| Cook Medical LLC | $95.80 | 2025 | Hemospray |
| Janssen Biotech, INC. | $76.32 | 2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $51.42 | 2025 | Entyvio |
| Ardelyx, INC. | $50.22 | 2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $47.62 | 2024 | Voquezna |
| Abbvie INC. | $45.81 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $40.75 | 2024 | Dupixent |
| Gilead Sciences, INC. | $36.72 | 2025 | Livdelzi |
| Boston Scientific Corporation | $29.56 | 2023 | Wavewriter Alpha Prime 16 |
| Actelion Pharmaceuticals US, INC. | $19.63 | 2019 | |
| Nalu Medical, INC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.